Controlled high efficiency lesion formation using high intensity ultrasound

• US 6,626,855 B1
• Filed: 11/22/2000
• Issued: 09/30/2003
• Est. Priority Date: 11/26/1999
• Status: Expired due to Fees

• Current Assignee: Otsuka Medical Devices Co., Ltd. (Otsuka Holdings Company Limited)
• Original Assignee: Therus Corp. (Boston Scientific Corporation)
• Inventors: Zhang, Jimin, Perozek, David M., Weng, Lee
• Primary Examiner(s): Lateef, Marvin M.
• Assistant Examiner(s): QADERI, RUNA S
• Application Number:
  US09/721,526
• Time in Patent Office: 1,042 Days
• Field of Search: 601/2, 601/3, 600/437, 600/438, 600/442
• US Class Current: 601/3
• CPC Class Codes: A61B 2017/4216 Operations on uterus, e.g. endometrium
• CPC Class Codes: A61B 2090/378 using ultrasound
• CPC Class Codes: A61B 8/12 in body cavities or body tracts, e.g. by using catheters catheters per se A61M25/00
• CPC Class Codes: A61B 8/4281 characterised by sound-transmitting media or devices for coupling the transducer to the tissue
• CPC Class Codes: A61B 8/445 Details of catheter construction
• CPC Class Codes: A61B 8/546 involving monitoring or regulation of device temperature
• CPC Class Codes: A61N 2007/0052 using the same transducer for therapy and imaging
• CPC Class Codes: A61N 7/00 Ultrasound therapy lithotripsy A61B17/22, A61B17/225; massage using supersonic vibration A61H23/00 ; using ultrasound for introducing media into the body A61M37/0092
• CPC Class Codes: A61N 7/02 Localised ultrasound hyperthermia hyperthermia in general A61F7/00
• CPC Class Codes: A61N 7/022 intracavitary

Abstract

An ultrasound system used for both imaging and delivery high intensity ultrasound energy therapy to treatment sites and a method for treating tumors and other undesired tissue within a patient'"'"'s body with an ultrasound device. The ultrasound device has an ultrasound transducer array disposed on a distal end of an elongate, relatively thin shaft. In one form of the invention, the transducer array is disposed within a liquid-filled elastomeric material that more effectively couples ultrasound energy into the tumor, that is directly contacted with the device. Using the device in a continuous wave mode, a necrotic zone of tissue having a desired size and shape (e.g., a necrotic volume selected to interrupt a blood supply to a tumor) can be created by controlling at least one of the f-number, duration, intensity, and direction of the ultrasound energy administered. This method speeds the therapy and avoids continuously pausing to enable intervening normal tissue to cool.

Claims

1. An ultrasonic system for the treatment of tissue inside a patient'"'"'s body, comprising:

(a) a probe configured to be inserted into a patient'"'"'s body;

(b) at least an ultrasonic transducer located at a distal end of the probe and coupled to a power supply which energizes the ultrasonic transducer;

said ultrasonic transducer producing a focused beam of high intensity ultrasonic energy; and

(c) an ultrasound transmissive interface located at the distal end of the probe;

said ultrasound transmissive interface comprising an in-vivo, biocompatible cap having an opening disposed opposite the ultrasonic transducer and at least a passage and which is sealingly secured to a surface of tissue; and

a liquid disposed between the cap and the ultrasonic transducer.

2. The ultrasonic system of claim 1, wherein the cap comprises a double lipped rim around a perimeter of the cap and the at least a passage is configured to adapt to a vacuum to sealingly secure the cap to the surface of tissue.

3. A method for administering an ultrasonic therapy, comprising the steps of:

(a) providing at least an ultrasonic transducer that emits a focused high intensity ultrasonic energy when energized;

(b) positioning the at least ultrasonic transducer proximate an undesired tissue;

(c) positioning a focal point of the at least an ultrasonic transducer to a distal boundary of the undesired tissue;

(d) energizing the ultrasonic transducer and applying a sufficient thermal dose of focused high intensity ultrasonic energy to form an initial tissue lesion located at the distal boundary of the undesired tissue;

(e) initiating pre-focal heating of the undesired tissue to a sufficient temperature wherein at least one acoustic absorption characteristic of the heated undesired tissue is enhanced; and

(f) using at least one of an f-number, an intensity, and a time of the focused high intensity ultrasonic energy to cause the initial lesion to grow toward the ultrasonic transducer and in at least one other dimension, but not substantially beyond the distal boundary of the lesion.

4. The method of claim 3, further comprising the step of repositioning the ultrasonic transducer to direct the high intensity ultrasonic energy at a different portion of the undesired tissue mass, to achieve the desired shape and size of the necrotic zone.

5. The method of claim 3, wherein the desired shape and size of the necrotic zone are selected so that formation of the necrotic zone substantially deprives the undesired tissue mass of a blood supply, causing the ultimate destruction of the undesired tissue mass.

6. The method of claim 3, wherein the desired shape and size of the necrotic zone are selected to control bleeding at a treatment site.